OrielJDPartridgeBMDennyMJColemanJC. Genital yeast infections. Br Med J1972; 4: 761–4.
4.
VeroT. Comparative study of local and oral treatment of vaginal candidiasis (Caesten-Nizoral). Ther Hung1987; 35: 208–12.
5.
Van TyleJH. Ketoconazole—mechanism of action, spectrum of activity, pharmacokinetics, drug interaction, adverse reactions and therapeutic use. Pharmacotherapy1984; 4: 343–73.
6.
MilesMROlsenLRogersA. Recurrent vaginal candidiasis: Importance of an intestinal reservoir. JAMA1977; 238: 1836–7.
7.
BisschopMPJMMerkusJMWMScheygrondHVan CutsemJVan De KuyA. Treatment of vaginal candidiasis with ketoconazole: A new, orally active, antimycotic. Eur J Obstet Gynecol Reprod Biol1979; 9: 253–9.
8.
KutzerEOittneRLeodolterSBrammerKW. A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis; report of a double-blind multicentre trial. Eur J Obstet Gynecol Reprod Biol1988; 29: 305–13.
9.
BalsdonMJRosedaleNBlatchfordNRJonesJ. The systemic treatment of recurrent vaginal candidosis: An evaluation of oral ketoconazole therapy. Curr Ther Res1982; 31: 511–6.
10.
BlochBSmytheE. Ketoconazole in the treatment of vaginal candidiasis. S Afr Med J1985; 67: 178–9.
11.
Silva-CruzADuarteV. The management of genital candidosis with an oral antimycotic agent, ketoconazole. Pharmacotherapeutica1986; 4: 411–5.
12.
SugarAMAlsipSGGalgianiJN, Pharmacology and toxicity of high dose ketoconazole. Antimicrob Agents Chemother1987; 31: 1874–8.
13.
FleuryFHughesDFloydR. Therapeutic results obtained in vaginal mycoses after single-dose treatment with 500 mg clotrimazole vaginal tablets. Am J Obstet Gynecol1985; 152: 968–70.
14.
GoormansEBergsteinNAMLoenderslootEWBranolteJH. One-dose therapy of Candida vaginitis: I. Results of an open multicentre trial. Chemotherapy1982; 28 (suppl 1): 106–9.
15.
KrauseU. Results of single-dose treatment of vaginal mycoses with 500 mg Canesten vaginal tablets. Chemotherapy1982; 28 (suppl 1): 99–105.
